Literature DB >> 12121502

Hepatorenal syndrome in patients with cirrhosis.

Richard Moreau1.   

Abstract

Type 1 hepatorenal syndrome (HRS) is a severe complication of end-stage cirrhosis. Type 1 HRS is an acute functional renal failure (i.e. glomerular hypofiltration) with no other explanation than the presence of the circulatory and neurohumoral alterations associated with severe chronic liver disease. Plasma volume expansion does not improve renal function. In contrast, administration of the vasopressin analog terlipressin, a splanchnic and systemic vasoconstrictor, may improve renal function and be used while awaiting liver transplantation. Copyright 2002 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121502     DOI: 10.1046/j.1440-1746.2002.02778.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia.

Authors:  Guang-Dong Tong; Da-Qiao Zhou; Jing-Song He; Lai Zhang; Zhi-Fei Chen; Chun-Ling Xiao; Li-Sheng Peng
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

2.  The course of type 1 hepato-renal syndrome post liver transplantation.

Authors:  Paul E Marik; Kelly Wood; Thomas E Starzl
Journal:  Nephrol Dial Transplant       Date:  2005-10-25       Impact factor: 5.992

3.  Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.

Authors:  Todd V Brennan; Keri E Lunsford; Parsia A Vagefi; Alan Bostrom; Michael Ma; Sandy Feng
Journal:  Clin Transplant       Date:  2014-11-17       Impact factor: 2.863

4.  Terlipressin for catecholamine-resistant septic shock in children.

Authors:  Antonio Rodríguez-Núñez; Manuel Fernández-Sanmartín; Federico Martinón-Torres; Natalia González-Alonso; José María Martinón-Sánchez
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

5.  A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

Authors:  Arun J Sanyal; Thomas Boyer; Guadalupe Garcia-Tsao; Frederick Regenstein; Lorenzo Rossaro; Beate Appenrodt; Andres Blei; Veit Gülberg; Samuel Sigal; Peter Teuber
Journal:  Gastroenterology       Date:  2008-02-13       Impact factor: 22.682

6.  Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study.

Authors:  Kamesh Gupta; Pooja Rani; Anurag Rohatgi; Mukesh Verma; Shivani Handa; Keemi Dalal; Anand Jain
Journal:  Clin Exp Gastroenterol       Date:  2018-09-18

7.  Effects of Shehuang Paste on hemodynamics, endotoxin, nitric oxide and endothelin-1 in patients with refractory cirrhotic ascites.

Authors:  Guang-dong Tong; Da-qiao Zhou; Jin-song He; Song-lin Li; Li-sheng Peng
Journal:  Chin J Integr Med       Date:  2006-12       Impact factor: 2.626

8.  Rescue treatment with terlipressin in children with refractory septic shock: a clinical study.

Authors:  Antonio Rodríguez-Núñez; Jesús López-Herce; Javier Gil-Antón; Arturo Hernández; Corsino Rey
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.